SynMetabio today announced that it has raised over RMB 100 million in its Series A financing round.This round was jointly led by Erdos Group and Heda Jinfu, with participation from Nest Bio.

CEC Capital acted as the sole financial advisor to SynMetabio in this transaction.

Erdos Group is a benchmark enterprise in China’s textile and apparel industry, and a diversified industrial group spanning energy and power, low-carbon metallurgy, and green chemicals. As a strategic industrial investor, the group has deeply participated in this financing.

Heda Jinfu is the manager of Zhejiang Province’s “4+1” biomedical and high-end medical device industry fund, participating in this round as a state-backed investor. Nest Bio is a professional investment firm focused on cutting-edge life science innovation, with continued investments across related sectors, and participated in this round as a co-lead follower investor.

The proceeds from this financing will be primarily used to support the company’s commercialization expansion and capacity building, as well as to accelerate technological innovation and product iteration of bio-based leather through AI-enabled development.

Founded in 2021, SynMetabio is committed to integrating advanced synthetic biology with materials modification science, while leveraging AI across its full R&D and production workflow. The company aims to create a new generation of bio-based materials—represented by bio-based leather—shifting high-performance materials used in consumer products from petroleum-based sources to bio-based alternatives.